Published Sep 20, 2021

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38

Dr. Matthew Johnson delves into the transformative power of psychedelics for treating mental disorders, examining their neurochemical impact, cultural and legal shifts, and the therapeutic settings crucial for efficacy and safety. Amidst growing societal acceptance, Andrew Huberman and Dr. Johnson discuss potential benefits and the complexities of managing risks associated with these profound substances.
Episode Highlights
Huberman Lab logo

Popular Clips

Episode Highlights

  • Bad Trips

    Bad trips during psychedelic experiences can be profoundly unsettling, often characterized by a sense of losing touch with reality. explains that these experiences can feel like "reality is sort of shattering," leading to intense fear and a feeling of going insane 1. The key to managing such experiences lies in the approach: surrendering to the experience rather than resisting it can lead to transcendental outcomes. emphasizes the importance of context and safety, noting that while bad trips are atypical, they can result in dangerous situations if not properly managed 2.

       

    Psychological Risks

    Psychedelics carry potential long-term psychological risks, including Hallucinogen Persisting Perception Disorder (HPPD) and psychosis. discusses the phenomenon of flashbacks, which are often misunderstood as being caused by residual compounds in the body 3. clarifies that HPPD is rare and not necessarily linked to psychedelic use, suggesting a neurological susceptibility in certain individuals. He also highlights the importance of screening for psychotic disorders before psychedelic use to prevent destabilization 4.

Related Episodes